BOC Sciences Intelligence Profile

bocsci.comLast reviewed: October 20, 2026Research coverage: 77%

Overall data confidence:Unknown

Identity confidence

Moderate

5 of 10 identity fields independently documented

Corporate continuity

Continuity supported — domain registered 2008-11-19; the vendor has issued dated press releases continuously from at least 2019 through 2026 describing the same chemical-supply business at the same Shirley, NY address; the site is live today with a current catalog and a promoted October 2026 conference appearance (AAPS PharmSci 360 2026, Booth #811).

Based on domain history and corporate record fields

Regulatory exposure

None identified

Derived from published risk flags

Evidence integrity

High

6 of 7 testing fields documented

Transaction transparency

Moderate

3 of 5 commercial fields documented

Change activity

None tracked

0 change events tracked

Research Incomplete

Research coverage for this vendor is 77%. Our research on BOC Sciences remains incomplete — what we have verified so far is published below, and research is continuing.

Still to research:

Research coverage ≥ 80%
Registration jurisdiction researched (state_of_registration)
Entity status researched (entity_status)
Refund policy reviewed (refund_return_policy)
Payment methods reviewed (accepted_payment_methods)
Public summary reviewed

Overview#

BOC Sciences (brand of BOCSCI Inc., per the vendor's own boilerplate) is a U.S.-headquartered B2B research-chemical and CRO/CDMO supplier at bocsci.com, operating from a consistently published address — 45-16 Ramsey Road, Shirley, NY 11967 — on a domain registered 2008-11-19. FIT: it genuinely sells peptides, both as catalog products (e.g., brain natriuretic peptide (1-32), pTH (53-84) at ≥95% by HPLC, semaglutide) and through extensive custom peptide synthesis services (SPPS, preparative HPLC purification, MS confirmation, delivered data packages) — but its model is quote/inquiry-based B2B supply to pharma, biotech, and academia, not a retail research-peptide storefront, and its pages restrict products to research/manufacturing use with no sales to patients. Transparency is materially stronger than the anonymous RUO baseline: a named legal entity (BOCSCI Inc.), a stable street address, and consistent phone/fax/email channels are published. The open verification gap is corporate-registry confirmation: the New York DOS record for BOCSCI Inc. could not be retrieved in this pass (portal requires an interactive session; fetch failed), so state of registration, entity status, formation date, registered agent, and principals remain Unknown, and published founding claims conflict (2005 vs 2007). All defined regulatory searches (FDA warning letters, recalls, import alerts; FTC; state AG; civil litigation; criminal/injunctive) returned No Record Found in the defined search — searches require care because 'BOC' results are dominated by Boston Scientific, Boca Pharmacal, and The BOC Group, all different companies. Testing disclosure is vendor-internal: COAs are furnished with shipment/on request rather than publicly posted, no independent laboratory is named (testing is represented as in-house HPLC/MS/NMR under GMP/ISO claims), and there is no public COA verification portal or dated public COA to assess recency. Payment and refund/return terms are not publicly published (B2B quotation model). No High/Critical severity findings.

Company Identity#

Vendor Brand NameBOC Sciences

HighSource: BOC Sciences homepage

Primary Website Domainbocsci.com

ModerateSource: BOC Sciences — official website (intake domain confirmation)

Legal Entity NameBOCSCI Inc.

ModerateSource: openPR press release — 'BOC Sciences is a brand of BOCSCI Inc.'; contact address 45-16 Ramsey Road, Shirley, NY 11967, USA; Email: info@bocsci.com

State of RegistrationNot independently verified

UnknownSource: New York Department of State — Corporation and Business Entity Database (public inquiry portal) — direct record retrieval attempted 2026-10-20; portal fetch failed (network error) and the inquiry requires an interactive form session, so no DOS record for BOCSCI Inc. was retrieved in this pass

Entity StatusNot independently verified

Incorporation / Formation DateNot independently verified

Named Principals / ManagersNot independently verified

UnknownSource: BOC Sciences homepage

Registered AgentNot independently verified

Operating Address45-16 Ramsey Road, Shirley, NY 11967, USA

HighSource: BOC Sciences product page footer — International: 1-631-504-6093; US & Canada (Toll free): 1-844-BOC(262)-0123; Fax: 1-631-614-7828; Email: info@bocsci.com; 45-16 Ramsey Road, Shirley, NY 11967, USA

Address ConsistencyConsistent — the street address 45-16 Ramsey Road, Shirley, NY 11967, USA is identical across the vendor's site footer, its press releases, and independent directories. Imprecision is in the city-level description only: some vendor boilerplate describes the company as 'Headquartered in New York' or 'headquartered in New York City', which is inconsistent with the Shirley (Long Island) street address; the street address itself does not vary.

ModerateSource: BOC Sciences product page footer — International: 1-631-504-6093; US & Canada (Toll free): 1-844-BOC(262)-0123; Fax: 1-631-614-7828; Email: info@bocsci.com; 45-16 Ramsey Road, Shirley, NY 11967, USA

Domain and Digital Identity#

Domain Registration Date2008-11-19

HighSource: Verisign RDAP — bocsci.com

Domain Ownership / Registrar Change HistoryPartially known — current registrar GoDaddy.com, LLC (IANA 146); RDAP record last changed 2026-10-13T02:17:49Z. Registrant identity is not disclosed in RDAP and earlier registrar/ownership history was not established in this pass.

LowSource: Verisign RDAP — bocsci.com

Website ContinuityContinuity supported — domain registered 2008-11-19; the vendor has issued dated press releases continuously from at least 2019 through 2026 describing the same chemical-supply business at the same Shirley, NY address; the site is live today with a current catalog and a promoted October 2026 conference appearance (AAPS PharmSci 360 2026, Booth #811).

ModerateSource: Verisign RDAP — bocsci.com

Contact Channel IntegrityPublished channels are consistent on the current site: International phone 1-631-504-6093, US & Canada toll-free 1-844-BOC(262)-0123, Fax 1-631-614-7828, Email info@bocsci.com, plus subdomain service emails (e.g., aapep@bocsci.com on the peptide subdomain) and the Shirley, NY street address in page footers. One legacy inconsistency: older press releases and directories list a different main phone, 1-631-485-4226, which still circulates in third-party listings alongside the current 1-631-504-6093. No conflicting address or email domain found.

Regulatory and Legal History#

FDA Warning Letter HistoryNo Record Found in the defined search

HighSource: Defined web search of fda.gov — no record naming BOC Sciences / BOCSCI Inc. / bocsci.com

FDA Recall / Safety Action HistoryNo Record Found in the defined search

ModerateSource: Defined web search of fda.gov — no record naming BOC Sciences / BOCSCI Inc. / bocsci.com

FDA Import Alert / Detention ExposureNo Record Found in the defined search

ModerateSource: Defined web search of fda.gov — no record naming BOC Sciences / BOCSCI Inc. / bocsci.com

FTC Enforcement HistoryNo Record Found in the defined search

HighSource: Defined web search of ftc.gov — no action naming BOC Sciences / BOCSCI Inc.

State Regulatory / Attorney General ActionsNo Record Found in the defined search

ModerateSource: Defined web search — BOC Sciences / BOCSCI Inc.

Relevant Civil LitigationNo Record Found in the defined search

ModerateSource: Defined web search — BOC Sciences / BOCSCI Inc.

Criminal / Injunctive ProceedingsNo Record Found in the defined search

ModerateSource: Defined web search — BOC Sciences / BOCSCI Inc.

Testing and COA Evidence#

Public COA AvailabilityCOAs are NOT publicly posted as downloadable documents on the product pages fetched — product pages state 'COA reports available' and the vendor states standard documentation (COA and MSDS) is available and that every shipped compound comes with a specification sheet / COA and MSDS. Availability is therefore on-request / with-shipment, not public pre-purchase posting.

ModerateSource: BOC Sciences (aapep.bocsci.com) — pTH (53-84) (human) peptide product page (Purity ≥95% by HPLC; 'COA reports available'; 'For research and manufacturing use only')

Batch / Lot SpecificityVendor-stated lot-specific documentation model, not independently verified from a public sample — the vendor's own QC guidance states a Certificate of Analysis should report the lot number (with HPLC purity and MS-confirmed molecular weight), and custom-synthesis deliveries are described as including a data package (HPLC chromatograms, mass spectra, amino acid analysis). No public peptide COA sample was available to inspect to confirm lot-specific practice in this pass.

LowSource: BOC Sciences — QC and Characterization of Fluorescent Labeled Nucleic Acids (vendor's own description of what a Certificate of Analysis should contain, incl. product identity, HPLC purity, MS molecular weight, and lot number)

Independent Laboratory IdentityNo independent third-party laboratory is named — testing and characterization are represented as performed in-house on the vendor's own analytical platform (HPLC, LC-MS, MS, NMR, GC-MS, IR) at its GMP-compliant / ISO-certified facilities. No external lab identity is published on the pages fetched.

ModerateSource: BOC Sciences — Analytical Development & QC services page (in-house HPLC, GC, MS, UV-Vis, FTIR and other QC methods)

COA Verification StatusNot verifiable through a public portal — no COA lookup or verification system was found on the vendor's site, and COAs are not publicly posted (see public_coa_availability), so a COA cannot be authenticated against the issuer online. Verification would require direct inquiry to the vendor.

ModerateSource: BOC Sciences homepage

Test RecencyNot independently verified

UnknownSource: BOC Sciences (aapep.bocsci.com) — pTH (53-84) (human) peptide product page (Purity ≥95% by HPLC; 'COA reports available'; 'For research and manufacturing use only')

Testing CoverageVendor-stated coverage is catalog- and project-wide: catalog peptide products list purity by HPLC (e.g., ≥95% by HPLC); custom peptide synthesis projects are described as purified by preparative (RP-)HPLC and confirmed by MS with a delivered data package (HPLC chromatograms, mass spectra, amino acid analysis); the broader analytical platform is described as HPLC, GC, MS, NMR, GC-MS and LC-MS under a cGMP quality system. All coverage figures here are vendor representations; no independent test records were located.

ModerateSource: BOC Sciences (aapep.bocsci.com) — pTH (53-84) (human) peptide product page (Purity ≥95% by HPLC; 'COA reports available'; 'For research and manufacturing use only')

Evidence ConsistencyGenerally consistent on the core facts — the same Shirley, NY street address, contact block, BOCSCI Inc. brand statement, and peptide/chemical catalog appear across the vendor's site, subdomains, press releases, and directories, and no falsified-testing-evidence indicators were found. Inconsistencies noted: (1) founding year is given as 2005 by CB Insights but 'starting from 2007' in the vendor's own press releases, and neither matches the 2008 domain registration — longevity claims should be treated as uncorroborated; (2) headquarters is variously described as Shirley, NY / 'New York' / 'New York City'; (3) two main phone numbers circulate (current 1-631-504-6093 vs legacy 1-631-485-4226 in older releases and directories).

ModerateSource: CB Insights — BOC Sciences company profile (HQ 45-16 Ramsey Road, Shirley, New York 11967; phone 631-485-4226; founded listed as 2005)

Payment, Refund and Shipping#

Accepted Payment MethodsNot independently verified

UnknownSource: BOC Sciences — Brain natriuretic peptide (1-32) (human) product page (peptide catalog product; 'not to be used for therapeutic purposes / cannot be sold to patients')

Refund / Return PolicyNot independently verified

UnknownSource: Defined web search — BOC Sciences / BOCSCI Inc.

Shipping & Fulfillment RepresentationsThe vendor represents worldwide delivery and prompt dispatch: the homepage advertises 'Prompt delivery & Multiple quantities'; peptide product pages badge 'Worldwide Delivery' and claim 'In-stock supply in the US and Europe' with scale 'from mg and g to kg-scale production'; product pages carry a standing warning that products are not for therapeutic purposes and cannot be sold to patients, and the peptide subdomain states 'For research and manufacturing use only. We do not sell to patients.' No specific carrier, transit-time, or shipping-fee schedule is published on the pages fetched (quote-based B2B fulfillment).

ModerateSource: BOC Sciences homepage

Terms / Policy StabilityIntake pass — the vendor's core use restrictions (research/manufacturing use only; not for therapeutic purposes; no sales to patients) and its Privacy Policy reference appear on current product pages and are consistent with the vendor's long-standing B2B positioning in dated press releases. Full Terms text was not retrieved in this pass, so no term-by-term stability assessment is made; future refresh cycles can diff policy pages directly.

LowSource: BOC Sciences — Brain natriuretic peptide (1-32) (human) product page (peptide catalog product; 'not to be used for therapeutic purposes / cannot be sold to patients')

Customer Complaint PatternNo documented complaint pattern in the defined search — targeted searches for BOC Sciences complaints/reviews returned no BBB or regulator complaint record and no recurring fulfillment/quality complaint theme; the vendor's own service pages carry only curated positive client testimonials (not treated as independent evidence), and a third-party place listing shows a 4.3-star rating based on 11 reviews without an extracted complaint theme. Recorded as absence of a pattern in Tier 3 search results only.

LowSource: Defined web search — BOC Sciences / BOCSCI Inc.

Material Changes#

No material changes recorded.

Sources#

New York Department of State — Corporation and Business Entity Database (public inquiry portal) — direct record retrieval attempted 2026-10-20; portal fetch failed (network error) and the inquiry requires an interactive form session, so no DOS record for BOCSCI Inc. was retrieved in this passTier 1 · AuthoritativeSos Business SearchAuthoritative

Retrieved: October 20, 2026